Search

Your search keyword '"Chagas Cardiomyopathy diagnostic imaging"' showing total 160 results

Search Constraints

Start Over You searched for: Descriptor "Chagas Cardiomyopathy diagnostic imaging" Remove constraint Descriptor: "Chagas Cardiomyopathy diagnostic imaging"
160 results on '"Chagas Cardiomyopathy diagnostic imaging"'

Search Results

1. Impact of cardiac structure and function on exercise intolerance in Chagas cardiomyopathy: Insights from CPET and echocardiography.

2. Myocardial Fibrosis by Magnetic Resonance and Outcomes in Chagas Disease: A Systematic Review and Meta-Analysis.

3. Pentoxifylline reduces inflammation and prevents myocardial perfusion derangements in experimental chronic Chagas' cardiomyopathy.

4. Autonomic denervation, myocardial hypoperfusion and fibrosis may predict ventricular arrhythmia in the early stages of Chagas cardiomyopathy.

5. WHF Recommendations for the Use of Echocardiography in Chagas Disease.

6. Regional myocardial sympathetic denervation precedes the development of left ventricular systolic dysfunction in chronic Chagas' cardiomyopathy.

8. Association of left ventricular abnormalities with incident cerebrovascular events and sources of thromboembolism in patients with chronic Chagas cardiomyopathy.

9. Three and two-dimensional cardiac mechanics by speckle tracking are predictors of outcomes in chagas heart disease.

10. Myocardial Injury in Patients With Acute and Subacute Chagas Disease in the Brazilian Amazon Using Cardiovascular Magnetic Resonance.

12. The Volume-Time Curve by Three-Dimensional Echocardiography in Chagas Cardiomyopathy: Insights into the Mechanism of Hemodynamic Adaptations.

13. Electrocardiogram abnormalities in chronic Chagas cardiomyopathy correlate with scar mass and left ventricular dysfunction as assessed by cardiac magnetic resonance imaging.

14. Myocardial function reclassification: Echocardiographic strain patterns in patients with chronic Chagas cardiomyopathy and intraventricular dyssynchrony.

15. Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?

16. Clinical, electrocardiographic and echocardiographic evolution of chronic Chagas disease treated with nifurtimox on prolonged follow-up in Chile: observational study.

17. Accuracy and reliability of focused echocardiography in patients with Chagas disease from endemic areas: SaMi-Trop cohort study.

19. Association between myocardial mechanical dispersion and ventricular arrhythmogenicity in chagas cardiomyopathy.

20. Accuracy of health-related quality of life in identifying systolic dysfunction in patients with Chagas cardiomyopathy.

21. Tissue Inhibitor of Metalloproteinase-1 Is Increased in Chagasic Cardiomyopathy.

22. Advanced Therapies for Ventricular Arrhythmias in Patients With Chagasic Cardiomyopathy: JACC State-of-the-Art Review.

23. Exercise training improves microvascular function in patients with Chagas heart disease: Data from the PEACH study.

24. Histologic comparison in two Doberman pinschers with a dilated cardiomyopathy phenotype.

25. Speckle tracking echocardiography in the indeterminate form of Chagas disease.

28. Chagas Cardiomyopathy as the Etiology of Suspected Coronary Microvascular Disease. A Comparison Study with Suspected Coronary Microvascular Disease of Other Etiologies.

29. Early impairment of myocardial deformation assessed by regional speckle-tracking echocardiography in the indeterminate form of Chagas disease without fibrosis detected by cardiac magnetic resonance.

30. Cardiac magnetic resonance imaging in Chagas' disease: a parallel with electrophysiologic studies.

31. Associations between Cardiac Magnetic Resonance T1 Mapping Parameters and Ventricular Arrhythmia in Patients with Chagas Disease.

32. A Latin American Patient With a Left Ventricular Pseudoaneurysm Presenting With Progressive Dyspnea and Palpitations.

33. Chagas heart disease: A contemporary review.

34. Relationship between microvascular changes, autonomic denervation, and myocardial fibrosis in Chagas cardiomyopathy: Evaluation by MRI and SPECT imaging.

35. Echocardiographic parameters, speckle tracking, and brain natriuretic peptide levels as indicators of progression of indeterminate stage to Chagas cardiomyopathy.

36. Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy.

37. Prolonged dipyridamole administration reduces myocardial perfusion defects in experimental chronic Chagas cardiomyopathy.

38. Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility.

39. Case 4/2019 - 26-Year-Old Man with Congenital Chagas Disease and Heart Transplantation.

40. Comparison of the amount and patterns of late enhancement in Chagas disease according to the presence and type of ventricular tachycardia.

41. Echocardiography in Indigenous Populations and Resource Poor Settings.

42. Speckle tracking echocardiographic deformation indices in Chagas and idiopathic dilated cardiomyopathy: Incremental prognostic value of longitudinal strain.

43. An Unusual Suspect in a Case of Left Ventricular Aneurysm.

44. Incidence and variables associated with arrhythmias during dobutamine-atropine stress echocardiography among patients with Chagas disease.

45. Potential Role of PET in Assessing Ventricular Arrhythmias.

46. Cardiac Evaluation in the Acute Phase of Chagas' Disease with Post-Treatment Evolution in Patients Attended in the State of Amazonas, Brazil.

47. Long-Term Prognostic Value of Myocardial Fibrosis in Patients With Chagas Cardiomyopathy.

48. Left Ventricular Scar and Prognosis in Chronic Chagas Cardiomyopathy.

49. Echocardiographic Study of the Coronary Sinus in the Indeterminate Form of Chagas Disease.

50. Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy.

Catalog

Books, media, physical & digital resources